Skip to main content
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · IEX Real-Time Price · USD
3.100
+0.110 (3.68%)
At close: Apr 26, 2024, 4:00 PM
3.230
+0.130 (4.19%)
After-hours: Apr 26, 2024, 7:03 PM EDT

Ovid Therapeutics Revenue

In the year 2023, Ovid Therapeutics had annual revenue of $391.70K, a decrease of -73.93%. Revenue in the quarter ending December 31, 2023 was $141.56K with 205.88% year-over-year growth.

Revenue (ttm)
$391.70K
Revenue Growth
-73.93%
P/S Ratio
559.62
Revenue / Employee
$9,792
Employees
40
Market Cap
219.20M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023391.70K-1.11M-73.93%
Dec 31, 20221.50M-206.88M-99.28%
Dec 31, 2021208.38M195.77M1,551.57%
Dec 31, 202012.62M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 447.48M
23andMe Holding Co. 247.99M
2seventy bio 100.39M
AVITA Medical 51.57M
Senseonics Holdings 22.39M
uniQure 15.84M
Lineage Cell Therapeutics 8.95M
Revenue Rankings

OVID News

More News